|Bid||86.28 x 1000|
|Ask||86.25 x 800|
|Day's Range||85.90 - 86.57|
|52 Week Range||74.79 - 95.19|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||40.51|
|Earnings Date||Apr 29, 2021|
|Forward Dividend & Yield||0.98 (1.14%)|
|Ex-Dividend Date||Feb 25, 2021|
|1y Target Est||91.75|
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Baxter International Inc.Global Credit Research - 12 Apr 2021New York, April 12, 2021 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Baxter International Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review discussion held on 7 April 2021 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion.This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:45 a.m. Eastern Time.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic, its Annual Meeting of Stockholders (the 2021 Annual Meeting) will again be held by means of a virtual format only.